VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas
NCT00025129
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Lymphoma
Small Intestine Cancer
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG:
laromustine
Sponsor
Vion Pharmaceuticals